Abstract:Abstract Background Periodontitis is a chronic infectious disease leading to bone resorption and periodontal tissue disruption under inflammatory stimulation. The osteogenic differentiation ability of mesenchymal stem cells (MSCs) is impaired under the inflammatory environment, which limits the effect of treatment. The cannabinoid receptor I (CB1) is the main effector of the endogenous cannabinoid system (ECS), and our previous study verified that CB1 could enhance the osteo/dentinogenic differentiation of dental MSCs, which might be a target for alveolar bone regeneration. However, the effect of CB1 on the osteogenic differentiation of MSCs derived from bone remains unknown. In present study, we investigated the role and mechanism of CB1 on mitochondrial function and osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs) under inflammatory environment. Methods Alkaline phosphatase (ALP) activity, alizarin red staining, quantitative calcium analysis, and osteogenic markers were used to detect the osteogenic differentiation ability of BMSCs. Real-time RT-PCR and Western blot were used to detect the gene expression. Seahorse Cell Mito Stress Test was used to detect the oxygen consumption rate (OCR). JC-10 assay was used to determine the mitochondrial membrane potential (MMP). Results CB1 increased osteogenic differentiation potential and mitochondrial energy metabolism, including the OCR, MMP, and enhanced the expressions of Nrf1 and Nrf2 in hBMSCs without or with TNF-α or INF-γ stimulation. Then, the inhibitor of mitochondrial electron transport chain (ETC), rotenone (ROT), inhibited the osteogenic differentiation in hBMSCs, and CB1 could rescue ROT impaired osteogenic differentiation potentials of hBMSCs without or with TNF-α or INF-γ stimulation. Activation of ETC by Coenzyme Q10 (CoQ10) could restore the impaired osteogenic differentiation of hBMSCs by depletion of CB1 without or with TNF-α or INF-γ stimulation. Mechanismly, CB1 could activate the JNK signaling pathway, p38 MAPK signaling pathway, and inhibit the Erk1/2 signaling pathway. Conclusions The activating of CB1 enhanced the osteogenic differentiation by rescuing the mitochondrial metabolism function in hBMSCs under the inflammatory environment, suggesting that CB1 is a potential target for enhancing bone regeneration under the inflammatory environment.

Activation Of Cannabinoid Receptor Cb2 Regulates Osteogenic And Osteoclastogenic Gene Expression In Human Periodontal Ligament Cells

Activation of Cannabinoid Receptor CB2 Regulates LPS-induced Pro-Inflammatory Cytokine Production and Osteoclastogenic Gene Expression in Human Periodontal Ligament Cells

CB1 Promotes Osteogenic Differentiation Potential of Periodontal Ligament Stem Cells by Enhancing Mitochondrial Transfer of Bone Marrow Mesenchymal Stem Cells

Downregulation of Rankl and Rankl/Osteoprotegerin Ratio in Human Periodontal Ligament Cells During Their Osteogenic Differentiation

The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1α,25-dihydroxyvitamin D3

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells.

Modulation of osteogenic potential by recombinant human bone morphogenic protein-2 in human periodontal ligament cells: effect of serum, culture medium, and osteoinductive medium.

Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply

HOXA10 Inhibit the Osteogenic Differentiation of Periodontal Ligament Stem Cells by Regulating Β-Catenin Localization and DKK1 Expression

[Decreased Phosphorylation of Mitogen Activated Protein Kinase and Protein Kinase B Contribute to the Inhibition of Osteogenic Differentiation Mediated by Activation of Toll Like Receptor in Human Periodontal Ligament Stem Cells].

ANGPTL4 Regulates the Osteogenic Differentiation of Periodontal Ligament Stem Cells.

Effects of cannabinoid receptor activation on Porphyromonas gingivalis lipopolysaccharide stimulation in human periodontal ligament stem cells in vitro

Effects of Calcitriol on the Expression of Vitamin D Receptor. RANKL and Osteoprotegerin in Human Periodontal Ligament Cells

The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition

[Expression of Osterix Mrna and Protein Induced by Recombinant Human Bone Morphogenetic Protein-2 in Human Periodontal Ligament Cells].

Co-culture with Periodontal Ligament Stem Cells Enhanced Osteoblastic Differentiation of MC3T3-E1 Cells and Osteoclastic Differentiation of RAW264.7 Cells.

Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.

Up-Regulated Osteogenic Transcription Factors During Early Response Of Human Periodontal Ligament Stem Cells To Cyclic Tensile Strain

[Expression of OPG and RANKL at Protein Level in Human Periodontal Ligament Cells and the Effect of 1alpha,25(oh)(2) Vitamin D(3) on the Secretion of OPG Protein in Vitro].